newsfilter
← Latest News
GlobeNewswire·

Portage Biotech Reports Business and Strategic Update

Prioritize the adenosine clinical candidates iNKT clinical development paused to focus resourcesCompany will evaluate range of strategic options WESTPORT, Conn., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Portage Biotech